Cardiovascular Prosthetic Devices Market By Type (Cardiac prosthetic devices, Vascular Prosthetic Devices), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Cardiovascular Prosthetic Devices Market

Cardiovascular prosthetic devices are mechanical devices implanted in the body to replace or supplement a malfunctioning heart or other cardiovascular organ. These devices are designed to help maintain normal function, improve quality of life, and increase life expectancy. Examples of cardiovascular prosthetic devices include artificial heart valves, pacemakers, and ventricular assist devices. The report provides market dynamics and trends related to the Cardiovascular Prosthetic Devices  systems market. The study estimates the revenue generated from the sales of Cardiovascular Prosthetic Devices  such as prosthetic heart valves, pacemaker, ventricular assist devices and others.

Key factors driving the growth of the cardiovascular prosthetic devices  market include  increase in the demand for minimally invasive surgeries, rise in the prevalence of chronic disease that require cardiovascular prosthetic device, and advancement in R & D activities in medical device industry. Increase in number of cardiovascular surgeries is anticipated to drive the application of cardiovascular prosthetic devices and boosts the market growth. For instance, according to National Library of Medicine in September 2022, it was reported that, more than 200,000 heart valve replacement surgeries are performed each year, globally with a predicted increment to 8,50,000 per year by 2050. In addition, according to National Library of Medicine in August 2022, almost 400,000 coronary artery bypass grafting (CABG) surgeries are performed each year making it the most performed major surgical procedure. The elderly population is at an increased risk of developing heart disease due to age-related changes in the body, such as an increase in cholesterol levels, decrease in elasticity of the arteries, and an accumulation of calcium deposits in the arteries. In addition, older individuals are more likely to have other health conditions that may contribute to the development of heart disease, such as diabetes and hypertension. Rise rise in number of geriatric population cause increase in prevalence of cardiac disease. This factor is anticipated to drive the market growth.

The market also offers growth opportunities to the key players in the market.  Increase in number of key players to manufacture Cardiovascular Prosthetic Devices  systems provide lucrative opportunities for growth and expansion of the market. Some of the major key players offering cardiovascular prosthetic device Everflex Peripheral Self-Expanding Stent System and Advisa MRI SureScan pacemaker (Medtronic Plc.), VascuFlex LOC multiple stent systems (B. Braun Melsungen AG)., and ACURATE neo2 Aortic Valve System (Boston scientific). In addition, increase in the number of products, and rise in number of key players are attributed to drive the growth of market. For instance, Abbott Laboratories, global medical technology business, provides prosthetic heart valves such as Epic Plus valve, Epic Plus Supra valve, Trifecta Valve with Glide Technology, SJM regent mechanical heart valve, SJM masters series mechanical heart valve.

The Cardiovascular Prosthetic Devices  Market is segmented into type, end user and region. On the basis of type, the market is categorized into cardiac prosthetic devices and vascular prosthetic devices. Cardiac prosthetic devices include prosthetic heart valves, pacemaker, ventricular assist devices and others. Others include annuloplasty rings, synthetic sutures, tissue patches. Vascular prosthetic devices include stents, synthetic grafts, and others. On the basis of end user, it is bifurcated into hospitals, clinics, and others. The others segment includes cardiac centers and ambulatory surgical centers. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players profiled in the study include Abbott Laboratories, B. Braun Melsungen, Medtronic, Edwards Lifesciences, Boston Scientific, Johnson & Johnson, Artivion, Inc., Biotronic, Meril Life Sciences Pvt. Ltd. and W. L. Gore & Associates, Inc. The players in the market have been actively engaged in the adoption various strategies such as acquisition, product approval and agreement to remain competitive and gain advantage over the competitors in the market. For instance, in January 2023, Abbott Laboratories, pharmaceutical and medical equipment manufacturing company, announced that the U.S. Food and Drug Administration (FDA) has approved the latest generation transcatheter aortic valve implantation (TAVI) system of the company, Navitor, to treat people with severe aortic stenosis who are at high or extreme risk for open-heart surgery.

Key Market Insights (Updated)

By type, the Cardiac prosthetic devices system segment was the highest revenue contributor to the market and is estimated to reach $31,167.4 million by 2031, with a CAGR of 8.3%. However, the vascular prosthetic devices segment is estimated to be the fastest-growing segment with a CAGR of 9.0% during the forecast period.

Based on end user, the hospitals segment was the highest revenue contributor to the market with a CAGR of 8.9% during the forecast period.

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 9.4% during the forecast period. 

Overview

The Cardiovascular Prosthetic Devices Market valued for $26,937.8 million in 2021 and is estimated to reach $61,469.8 million by 2031, exhibiting a CAGR of 8.6% from 2022 to 2031. Cardiovascular prosthetic devices are artificial implants, that replace damaged heart valves, help divert blood flow, or assist with cardiac pacing and other functions.These devices are typically implanted by a cardiac surgeon and have a significant impact on quality of life. They are also used to treat a variety of cardiac diseases, such as congenital heart defects, arrhythmias, coronary artery disease, heart failure, and valvular heart disease. These cardiovascular prosthetic devices are used in different types of surgeries such as coronary artery bypass grafting (CABG), valve replacement, aortic aneurysm repair, endovascular stenting, ventricular assist devices, transcatheter aortic valve replacement (TAVR) and others.

The growth of cardiovascular prosthetic devices market is driven by technological advancement for development of different cardiovascular prosthetic devices, rise in the number of cardiovascular diseases and various strategies adopted such as product launch and product approval by the market key players. Increase in the prevalence of cardiovascular diseases cause rise in the use of cardiovascular prosthetic devices and fuels the growth of market. For instance, according to report shared by Center for Disease Control and Prevention (CDC), in 2020, it was reported that, coronary heart disease is the most common type of heart disease, killing 382,820 people in the U.S.

Moreover, in 2020, about 2 in 10 deaths from coronary artery disease (CAD) happen in adults less than 65 years old. Thus, this factor is anticipated to rise in number of cardiovascular surgeries and increase in application of cardiovascular prosthetic devices and drives the growth of the market. In addition, rise in the number of cardiovascular surgeries is anticipated to drive the application of cardiovascular prosthetic devices which is anticipated to drive the growth of market. For instance, December 2021, according to report shared by The Warren Alpert Medical School, cardiovascular disease remains the leading cause of mortality in the U.S., with over 900,000 cardiac surgeries such as coronary artery bypass grafting, heart transplants, and valve replacements being performed in the U.S. annually.

Moreover, rise in the expenditure by government to develop healthcare infrastructure is anticipated to boost the growth of market. For instance, as per The Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019.

Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and applications used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for cardiovascular prosthetic devices application in cardiac surgeries for treatment, thereby boosting the market growth.

On the other hand, high cost of cardiovascular prosthetic devices and risk of complications associated with implantation of cardiovascular prosthetic devices are some factors that are anticipated to restrain the growth of the cardiovascular prosthetic devices market.

The cardiovascular prosthetic devices market is segmented into type, end user and region. On the basis of type the market is segmented into cardiac prosthetic devices and vascular prosthetic devices. Cardiac prosthetic devices include prosthetic heart valves, pacemaker, ventricular assist devices and others. Others include annuloplasty rings, synthetic sutures, tissue patches. Vascular prosthetic devices include stents, synthetic grafts, and others.

Others includes patches, vascular clip, and vascular embolization device. On the basis of end users the market is segmented into hospital, clinics, and others. Others includes cardiac centers and ambulatory surgical centers Region-wise; the market is analyzed across North America (U.S., Canada, Mexico), Europe (Germany, France, UK, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and Rest of Asia Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and Rest of LAMEA).

Some of the major companies that operate in the global cardiovascular prosthetic devices market include Abbott Laboratories, B. Braun Melsungen, Medtronic, Edwards Lifesciences, Boston Scientific, Johnson & Johnson, Artivion, Inc., Biotronic, Meril Life Sciences Pvt. Ltd. and W. L. Gore & Associates, Inc.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiovascular prosthetic devices market analysis from 2021 to 2031 to identify the prevailing cardiovascular prosthetic devices market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the cardiovascular prosthetic devices market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global cardiovascular prosthetic devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Abbott Laboratorie

Scope of Cardiovascular Prosthetic Devices Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in prevalence of cardiovascular diseases.

3.4.1.2. Rise in the number of cardiovascular surgeries.

3.4.1.3. Rise in the number of geriatric populations

3.4.2. Restraints

3.4.2.1. High cost of cardiovascular prosthetic devices

3.4.3. Opportunities

3.4.3.1. Increase in the number of product launch by market players

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Cardiac prosthetic devices

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.2.4. Cardiac prosthetic devices Cardiovascular Prosthetic Devices Market by Type

4.2.4.1. Prosthetic heart valves Market size and forecast, by region

4.2.4.2. Pacemaker Market size and forecast, by region

4.2.4.3. Ventricular assist devices Market size and forecast, by region

4.2.4.4. Others Market size and forecast, by region

4.3. Vascular Prosthetic Devices

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.3.4. Vascular Prosthetic Devices Cardiovascular Prosthetic Devices Market by Type

4.3.4.1. Stents Market size and forecast, by region

4.3.4.2. Synthetic grafts Market size and forecast, by region

4.3.4.3. Others Market size and forecast, by region

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Clinics

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast By Region

6.2. North America

6.2.1. Key trends and opportunities

6.2.2. Market size and forecast, by Type

6.2.2.1. North America Cardiac prosthetic devices Cardiovascular Prosthetic Devices Market by Type

6.2.2.2. North America Vascular Prosthetic Devices Cardiovascular Prosthetic Devices Market by Type

6.2.3. Market size and forecast, by End User

6.2.4. Market size and forecast, by country

6.2.4.1. U.S.

6.2.4.1.1. Key market trends, growth factors and opportunities

6.2.4.1.2. Market size and forecast, by Type

6.2.4.1.3. Market size and forecast, by End User

6.2.4.2. Canada

6.2.4.2.1. Key market trends, growth factors and opportunities

6.2.4.2.2. Market size and forecast, by Type

6.2.4.2.3. Market size and forecast, by End User

6.2.4.3. Mexico

6.2.4.3.1. Key market trends, growth factors and opportunities

6.2.4.3.2. Market size and forecast, by Type

6.2.4.3.3. Market size and forecast, by End User

6.3. Europe

6.3.1. Key trends and opportunities

6.3.2. Market size and forecast, by Type

6.3.2.1. Europe Cardiac prosthetic devices Cardiovascular Prosthetic Devices Market by Type

6.3.2.2. Europe Vascular Prosthetic Devices Cardiovascular Prosthetic Devices Market by Type

6.3.3. Market size and forecast, by End User

6.3.4. Market size and forecast, by country

6.3.4.1. Germany

6.3.4.1.1. Key market trends, growth factors and opportunities

6.3.4.1.2. Market size and forecast, by Type

6.3.4.1.3. Market size and forecast, by End User

6.3.4.2. France

6.3.4.2.1. Key market trends, growth factors and opportunities

6.3.4.2.2. Market size and forecast, by Type

6.3.4.2.3. Market size and forecast, by End User

6.3.4.3. UK

6.3.4.3.1. Key market trends, growth factors and opportunities

6.3.4.3.2. Market size and forecast, by Type

6.3.4.3.3. Market size and forecast, by End User

6.3.4.4. Italy

6.3.4.4.1. Key market trends, growth factors and opportunities

6.3.4.4.2. Market size and forecast, by Type

6.3.4.4.3. Market size and forecast, by End User

6.3.4.5. Spain

6.3.4.5.1. Key market trends, growth factors and opportunities

6.3.4.5.2. Market size and forecast, by Type

6.3.4.5.3. Market size and forecast, by End User

6.3.4.6. Rest of Europe

6.3.4.6.1. Key market trends, growth factors and opportunities

6.3.4.6.2. Market size and forecast, by Type

6.3.4.6.3. Market size and forecast, by End User

6.4. Asia-Pacific

6.4.1. Key trends and opportunities

6.4.2. Market size and forecast, by Type

6.4.2.1. Asia-Pacific Cardiac prosthetic devices Cardiovascular Prosthetic Devices Market by Type

6.4.2.2. Asia-Pacific Vascular Prosthetic Devices Cardiovascular Prosthetic Devices Market by Type

6.4.3. Market size and forecast, by End User

6.4.4. Market size and forecast, by country

6.4.4.1. Japan

6.4.4.1.1. Key market trends, growth factors and opportunities

6.4.4.1.2. Market size and forecast, by Type

6.4.4.1.3. Market size and forecast, by End User

6.4.4.2. China

6.4.4.2.1. Key market trends, growth factors and opportunities

6.4.4.2.2. Market size and forecast, by Type

6.4.4.2.3. Market size and forecast, by End User

6.4.4.3. India

6.4.4.3.1. Key market trends, growth factors and opportunities

6.4.4.3.2. Market size and forecast, by Type

6.4.4.3.3. Market size and forecast, by End User

6.4.4.4. Australia

6.4.4.4.1. Key market trends, growth factors and opportunities

6.4.4.4.2. Market size and forecast, by Type

6.4.4.4.3. Market size and forecast, by End User

6.4.4.5. South Korea

6.4.4.5.1. Key market trends, growth factors and opportunities

6.4.4.5.2. Market size and forecast, by Type

6.4.4.5.3. Market size and forecast, by End User

6.4.4.6. Rest of Asia-Pacific

6.4.4.6.1. Key market trends, growth factors and opportunities

6.4.4.6.2. Market size and forecast, by Type

6.4.4.6.3. Market size and forecast, by End User

6.5. LAMEA

6.5.1. Key trends and opportunities

6.5.2. Market size and forecast, by Type

6.5.2.1. LAMEA Cardiac prosthetic devices Cardiovascular Prosthetic Devices Market by Type

6.5.2.2. LAMEA Vascular Prosthetic Devices Cardiovascular Prosthetic Devices Market by Type

6.5.3. Market size and forecast, by End User

6.5.4. Market size and forecast, by country

6.5.4.1. Brazil

6.5.4.1.1. Key market trends, growth factors and opportunities

6.5.4.1.2. Market size and forecast, by Type

6.5.4.1.3. Market size and forecast, by End User

6.5.4.2. Saudi Arabia

6.5.4.2.1. Key market trends, growth factors and opportunities

6.5.4.2.2. Market size and forecast, by Type

6.5.4.2.3. Market size and forecast, by End User

6.5.4.3. South Africa

6.5.4.3.1. Key market trends, growth factors and opportunities

6.5.4.3.2. Market size and forecast, by Type

6.5.4.3.3. Market size and forecast, by End User

6.5.4.4. Rest of LAMEA

6.5.4.4.1. Key market trends, growth factors and opportunities

6.5.4.4.2. Market size and forecast, by Type

6.5.4.4.3. Market size and forecast, by End User

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Top player positioning, 2021

8.1. Abbott Laboratories

8.1.1. Company overview

8.1.2. Key Executives

8.1.3. Company snapshot

8.1.4. Operating business segments

8.1.5. Product portfolio

8.1.6. Business performance

8.1.7. Key strategic moves and developments

8.2. B Braun Melsungen AG

8.2.1. Company overview

8.2.2. Key Executives

8.2.3. Company snapshot

8.2.4. Operating business segments

8.2.5. Product portfolio

8.2.6. Business performance

8.3. Medtronic plc

8.3.1. Company overview

8.3.2. Key Executives

8.3.3. Company snapshot

8.3.4. Operating business segments

8.3.5. Product portfolio

8.3.6. Business performance

8.3.7. Key strategic moves and developments

8.4. Edwards Lifesciences

8.4.1. Company overview

8.4.2. Key Executives

8.4.3. Company snapshot

8.4.4. Operating business segments

8.4.5. Product portfolio

8.4.6. Business performance

8.4.7. Key strategic moves and developments

8.5. Boston Scientific Corporation

8.5.1. Company overview

8.5.2. Key Executives

8.5.3. Company snapshot

8.5.4. Operating business segments

8.5.5. Product portfolio

8.5.6. Business performance

8.5.7. Key strategic moves and developments

8.6. Johnson and Johnson

8.6.1. Company overview

8.6.2. Key Executives

8.6.3. Company snapshot

8.6.4. Operating business segments

8.6.5. Product portfolio

8.6.6. Business performance

8.7. Artivion, Inc.

8.7.1. Company overview

8.7.2. Key Executives

8.7.3. Company snapshot

8.7.4. Operating business segments

8.7.5. Product portfolio

8.7.6. Business performance

8.8. Biotronic

8.8.1. Company overview

8.8.2. Key Executives

8.8.3. Company snapshot

8.8.4. Operating business segments

8.8.5. Product portfolio

8.8.6. Key strategic moves and developments

8.9. Meril Life Sciences Pvt. Ltd.

8.9.1. Company overview

8.9.2. Key Executives

8.9.3. Company snapshot

8.9.4. Operating business segments

8.9.5. Product portfolio

8.10. W. L. Gore & Associates, Inc.

8.10.1. Company overview

8.10.2. Key Executives

8.10.3. Company snapshot

8.10.4. Operating business segments

8.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 02. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR CARDIAC PROSTHETIC DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 03. GLOBAL CARDIAC PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 04. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR PROSTHETIC HEART VALVES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 05. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR PACEMAKER, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 06. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 07. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 08. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR VASCULAR PROSTHETIC DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 09. GLOBAL VASCULAR PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 10. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR STENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 11. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR SYNTHETIC GRAFTS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 12. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 13. GLOBAL CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 14. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 15. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 16. CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 17. CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 18. NORTH AMERICA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 19. NORTH AMERICA CARDIAC PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 20. NORTH AMERICA VASCULAR PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 21. NORTH AMERICA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 22. NORTH AMERICA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 23. U.S. CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 24. U.S. CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 25. CANADA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 26. CANADA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 27. MEXICO CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 28. MEXICO CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 29. EUROPE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 30. EUROPE CARDIAC PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 31. EUROPE VASCULAR PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 32. EUROPE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 33. EUROPE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 34. GERMANY CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 35. GERMANY CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 36. FRANCE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 37. FRANCE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 38. UK CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 39. UK CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 40. ITALY CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 41. ITALY CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 42. SPAIN CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 43. SPAIN CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 44. REST OF EUROPE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 45. REST OF EUROPE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 46. ASIA-PACIFIC CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 47. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 48. ASIA-PACIFIC VASCULAR PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 49. ASIA-PACIFIC CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 50. ASIA-PACIFIC CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 51. JAPAN CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 52. JAPAN CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 53. CHINA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 54. CHINA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 55. INDIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 56. INDIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 57. AUSTRALIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 58. AUSTRALIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 59. SOUTH KOREA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 60. SOUTH KOREA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 61. REST OF ASIA-PACIFIC CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 62. REST OF ASIA-PACIFIC CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 63. LAMEA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 64. LAMEA CARDIAC PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 65. LAMEA VASCULAR PROSTHETIC DEVICES CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 66. LAMEA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 67. LAMEA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 68. BRAZIL CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 69. BRAZIL CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 70. SAUDI ARABIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 71. SAUDI ARABIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 72. SOUTH AFRICA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 73. SOUTH AFRICA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 74. REST OF LAMEA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 75. REST OF LAMEA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 76. ABBOTT LABORATORIES: KEY EXECUTIVES

TABLE 77. ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 78. ABBOTT LABORATORIES: PRODUCT SEGMENTS

TABLE 79. ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 80. ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 81. B BRAUN MELSUNGEN AG: KEY EXECUTIVES

TABLE 82. B BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

TABLE 83. B BRAUN MELSUNGEN AG: PRODUCT SEGMENTS

TABLE 84. B BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO

TABLE 85. MEDTRONIC PLC: KEY EXECUTIVES

TABLE 86. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 87. MEDTRONIC PLC: PRODUCT SEGMENTS

TABLE 88. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 89. MEDTRONIC PLC: KEY STRATERGIES

TABLE 90. EDWARDS LIFESCIENCES: KEY EXECUTIVES

TABLE 91. EDWARDS LIFESCIENCES: COMPANY SNAPSHOT

TABLE 92. EDWARDS LIFESCIENCES: PRODUCT SEGMENTS

TABLE 93. EDWARDS LIFESCIENCES: PRODUCT PORTFOLIO

TABLE 94. EDWARDS LIFESCIENCES: KEY STRATERGIES

TABLE 95. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES

TABLE 96. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 97. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS

TABLE 98. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 99. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES

TABLE 100. JOHNSON AND JOHNSON: KEY EXECUTIVES

TABLE 101. JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 102. JOHNSON AND JOHNSON: PRODUCT SEGMENTS

TABLE 103. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 104. ARTIVION, INC.: KEY EXECUTIVES

TABLE 105. ARTIVION, INC.: COMPANY SNAPSHOT

TABLE 106. ARTIVION, INC.: PRODUCT SEGMENTS

TABLE 107. ARTIVION, INC.: PRODUCT PORTFOLIO

TABLE 108. BIOTRONIC: KEY EXECUTIVES

TABLE 109. BIOTRONIC: COMPANY SNAPSHOT

TABLE 110. BIOTRONIC: PRODUCT SEGMENTS

TABLE 111. BIOTRONIC: PRODUCT PORTFOLIO

TABLE 112. BIOTRONIC: KEY STRATERGIES

TABLE 113. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES

TABLE 114. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT

TABLE 115. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT SEGMENTS

TABLE 116. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO

TABLE 117. W. L. GORE & ASSOCIATES, INC.: KEY EXECUTIVES

TABLE 118. W. L. GORE & ASSOCIATES, INC.: COMPANY SNAPSHOT

TABLE 119. W. L. GORE & ASSOCIATES, INC.: PRODUCT SEGMENTS

TABLE 120. W. L. GORE & ASSOCIATES, INC.: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN CARDIOVASCULAR PROSTHETIC DEVICES MARKET (2022-2031)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW BARGAINING POWER OF BUYERS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW THREAT OF NEW ENTRANTS

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCARDIOVASCULAR PROSTHETIC DEVICES MARKET

FIGURE 10. CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY TYPE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR CARDIAC PROSTHETIC DEVICES, BY COUNTRY 2021-2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR VASCULAR PROSTHETIC DEVICES, BY COUNTRY 2021-2031(%)

FIGURE 13. CARDIOVASCULAR PROSTHETIC DEVICES MARKET, BY END USER, 2021(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR CLINICS, BY COUNTRY 2021-2031(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR PROSTHETIC DEVICES MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 17. CARDIOVASCULAR PROSTHETIC DEVICES MARKET BY REGION, 2021

FIGURE 18. U.S. CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 19. CANADA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 20. MEXICO CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 21. GERMANY CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 22. FRANCE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 23. UK CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 24. ITALY CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 25. SPAIN CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 26. REST OF EUROPE CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 27. JAPAN CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 28. CHINA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 29. INDIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 30. AUSTRALIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 31. SOUTH KOREA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 32. REST OF ASIA-PACIFIC CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 33. BRAZIL CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 34. SAUDI ARABIA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 35. SOUTH AFRICA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 36. REST OF LAMEA CARDIOVASCULAR PROSTHETIC DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 37. TOP WINNING STRATEGIES, BY YEAR

FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 40. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 41. COMPETITIVE DASHBOARD

FIGURE 42. COMPETITIVE HEATMAP: CARDIOVASCULAR PROSTHETIC DEVICES MARKET

FIGURE 43. TOP PLAYER POSITIONING, 2021

FIGURE 44. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)

FIGURE 45. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 46. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 47. B. BRAUN SE: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 48. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 49. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 50. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)

FIGURE 51. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 52. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 53. EDWARDS LIFESCIENCES: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 54. EDWARDS LIFESCIENCES: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 55. EDWARDS LIFESCIENCES: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 56. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2019-2021 ($MILLION)

FIGURE 57. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 58. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 59. JOHNSON AND JOHNSON: SALES REVENUE, 2019-2021 ($MILLION)

FIGURE 60. JOHNSON AND JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 61. JOHNSON AND JOHNSON: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 62. ARTIVION, INC.: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 63. ARTIVION, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 64. ARTIVION, INC.: REVENUE SHARE BY REGION, 2021 (%